CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-23 | Daigneault Alessandra General Counsel & Secretary | Sale | −33,715 | $13.11 | $442K | 0 |
| 2021-08-19 | Daigneault Alessandra General Counsel & Secretary | Option exercise | +27,395 | $3.07 | $84K | 33,715 |
| 2021-08-19 | Daigneault Alessandra General Counsel & Secretary | Conversion · Employee Stock Option (Right to buy) | −43,000 | $3.07 | $132K | 100,840 |
| 2021-08-19 | Daigneault Alessandra General Counsel & Secretary | Grant or award · Restricted Stock Units | +15,605 | 15,605 | ||
| 2021-08-16 | Besthof Robert Chief Comm. & Patient Officer | Option exercise | +63,710 | $0.20 | $13K | 63,710 |
| 2021-08-16 | Besthof Robert Chief Comm. & Patient Officer | Conversion · Employee Stock Option (Right to buy) | −100,000 | $0.20 | $20K | 247,200 |
| 2021-08-16 | Besthof Robert Chief Comm. & Patient Officer | Grant or award · Restricted Stock Units | +36,290 | 36,290 | ||
| 2021-07-16 | Javitt Daniel C. 10% owner | Gift | −434,594 | 13,537,270 | ||
| 2021-07-16 | Javitt Daniel C. 10% owner | Gift | −434,594 | 13,102,676 | ||
| 2021-05-24 | Troy Daniel Director | Grant or award | +43,093 | 43,093 | ||
| 2021-05-24 | Troy Daniel Director | Grant or award · Employee Stock Option (Right to buy) | +65,437 | 65,437 | ||
| 2021-05-24 | Javitt Jonathan C Chief Executive Officer | Grant or award | +46,332 | 46,332 | ||
| 2021-05-24 | Javitt Jonathan C Chief Executive Officer | Grant or award | +13,348,997 | 13,348,997 | ||
| 2021-05-24 | Javitt Jonathan C Chief Executive Officer | Grant or award | +1,422,000 | 1,422,000 | ||
| 2021-05-24 | Javitt Daniel C. 10% owner | Grant or award | +13,971,864 | 13,971,864 | ||
| 2021-05-24 | Hurvitz Chaim Director | Grant or award | +1,436,350 | 1,436,350 | ||
| 2021-05-24 | Hurvitz Chaim Director | Grant or award | +208,443 | 208,443 | ||
| 2021-05-24 | Hurvitz Chaim Director | Grant or award · Common Stock Warrant (Right to buy) | +218,423 | 218,423 | ||
| 2021-05-24 | Gorovitz Aaron Director | Grant or award | +8,336 | 8,336 | ||
| 2021-05-24 | Gorovitz Aaron Director | Grant or award | +8,336 | 8,336 |
Page 4 of 6 · 108 trades